Skip to main content

Advertisement

Log in

Perioperative and adjuvant treatments for gastric cancer. Definitive new standards of care or are we still on the way?

  • Editorial
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cuschieri A, Weeden S, Fielding J et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MCR randomized surgical trial. Br J Cancer 79:1522–1530

    Article  PubMed  CAS  Google Scholar 

  2. Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340:908–914

    Article  PubMed  CAS  Google Scholar 

  3. Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820

    Article  PubMed  CAS  Google Scholar 

  4. Csendes A, Burdiles P, Rojas J et al (2002) A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 with gastric carcinoma. Surgery 131:401–407

    Article  PubMed  Google Scholar 

  5. Siewert JR, Bötcher K, Stein HJ et al (1998) Relevant prognostic factors in gastric cancer. Ann Surg 228:449–461

    Article  PubMed  CAS  Google Scholar 

  6. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730

    Article  PubMed  CAS  Google Scholar 

  7. Manterola C, Torres R, Burgos L et al (2006) Calidad metodológica de un artículo de tratamiento de cáncer gástrico adoptado como protocolo por algunos hospitales chilenos. Rev Med Chile 134:920–926

    PubMed  Google Scholar 

  8. Cunningham D, Allum WH, Stenning S et al (2006) Perioperative chemotherapy versus surgery alone for respectable gastroesophageal cancer. N Engl J Med 355:11–20

    Article  PubMed  CAS  Google Scholar 

  9. Ajani JA, Mansfield PF, Crane CH et al (2005) Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 23:1237–1244

    Article  PubMed  CAS  Google Scholar 

  10. Lordick F, Ott K, Krause BJ et al (2007) PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 8:797–805

    Article  PubMed  Google Scholar 

  11. Yu W, Whang I, Chung HY et al (2001) Indications for early postoperative intraperitoneal chemotherapy of advanced gastric cancer: results of a prospective randomized trial. World J Surg 25:985–990

    Article  PubMed  CAS  Google Scholar 

  12. Lenz HJ, Lee FC, Haller DG et al (2007) Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated advanced gastric carcinoma in a multicenter phase II study. Cancer 109:33–40

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. J. Lacueva.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lacueva, F.J., Oliver, I. Perioperative and adjuvant treatments for gastric cancer. Definitive new standards of care or are we still on the way?. Clin Transl Oncol 9, 747–748 (2007). https://doi.org/10.1007/s12094-007-0134-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-007-0134-0

Navigation